The Robert A. Winn Diversity in Clinical Trials Award Program is a national effort funded through philanthropic investment that seeks to train and mentor physicians from underrepresented backgrounds.
The fifth Health in History series event co-hosted by the MCV Foundation and the Virginia Museum of History & Culture featured Henry Donahue, Ph.D., a professor at the VCU College of Engineering, who has worked with NASA since 2011 studying the health effects of space travel.
A recent gift to elevate the Fay O. Redwine, M.D., Faculty Fund to an endowed chair cements Dr. Redwine’s legacy by investing in faculty excellence in obstetrics and gynecology.
The Walter Lawrence Jr., M.D., Chair in Oncology advances surgical oncology and cancer research while driving equity and access in patient care.
Gerry Moeller, M.D., a national leader in addiction research, is one of the reasons VCU ranks 11th nationally for NIDA-funded research into substance abuse disorders.
May is Mental Health Awareness Month. This year, the MCV Foundation worked with the VCU’s Department of Psychiatry to highlight alumni, faculty, researchers and donors who are combating mental health challenges in Richmond and around the world.
Kenneth S. Kendler's, M.D., research examines the ways in which molecular genetics coupled with environmental factors lead to psychiatric disorders like alcoholism, depression, anxiety, eating disorders, drug abuse and other challenges.
VCU’s Medicines for All Institute is at the center of a growing regional hub that will address pharmaceutical supply and manufacturing challenges around the world.
A VCU School of Nursing alumna’s support for a community engagement fund is fueling a still-expanding wellness program in Central Virginia.
As the country’s oldest civilian burn center, VCU Health’s Evans-Haynes Burn Center celebrates 75 years of testing and developing the best standards of care.
VCU Health’s position as a global leader in fighting opioid use disorder includes recent efforts to reverse the toxicity of a potent synthetic opioid, and the university’s strength in addiction research continues to drive innovation in treatment programs.
VCU researchers have engineered a virus to target and kill cancer cells.
Your generosity inspires innovation, encourages excellence and transforms dreams into discoveries. Discover your great place in the VCU Health community.
Giving
